Small extracellular vesicles as biomarkers and therapeutic targets in breast Cancer
Clinica Chimica Acta · 2026-06 · 588 · 120989
DOI: 10.1016/j.cca.2026.120989 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinica Chimica Acta, 2026-06. Verfasst von Kamel A Saleh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Small extracellular vesicles (sEVs) represent a novel frontier in oncology, functioning as critical mediators of intercellular communication that profoundly influence the biology of breast cancer. These nano-sized particles, typically ranging from 30 to 200 nm in diameter, are released by virtually all cell types into the extracellular space and circulate in biofluids like blood, urine, and saliva. Encased within a lipid bilayer, sEVs carry a complex molecular payload including proteins, lipids, various nucleic acids like microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), and metabolites that reflects the physiological or pathological state of their parent cell. In the context of breast cancer, these vesicles are not merely cellular debris but are active participants in orchestrating tumor progression, shaping the tumor microenvironment (TME), facilitating metastasis, and mediating resistance to therapies. This dual nature positions sEVs at the heart of precision medicine, offering immense potential as minimally invasive "liquid biopsies" for real-time diagnosis, prognosis, and treatment monitoring, while simultaneously presenting themselves as powerful tools for targeted therapeutic intervention. This review provides a comprehensive investigation into the multifaceted roles of sEVs in breast cancer, examining their applications as biomarkers and therapeutic targets across all major subtypes, integrating insights on underlying biological mechanisms, and critically evaluating their path toward clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
- College of Pharmacy, Alnoor University, Mosul, Iraq. Electronic address: ahmed.faisal@alnoor.edu.iq.
- Department of Maxillofacial Surgery, Samarkand State Medical University, 18 Amir Temur Street, Samarkand 140100, Uzbekistan.
- Department of Medical Fundamental Sciences, Termez University of Economics and Service, Termez, Uzbekistan.
- Al-Zahrawi University College, Karbala, Iraq.
- Pharmacy college, Al-Farahidi University, Baghdad, Iraq.
Zitieren
APA
Saleh, K. A., Mutee, A. F., Kubaev, A., Ochilova, D., Salih, R. M., Jaber, M. A., & Hussen, S. (2026). Small extracellular vesicles as biomarkers and therapeutic targets in breast Cancer. Clinica Chimica Acta, 588, 120989. https://doi.org/10.1016/j.cca.2026.120989
Vancouver
Saleh KA, Mutee AF, Kubaev A, Ochilova D, Salih RM, Jaber MA, et al. Small extracellular vesicles as biomarkers and therapeutic targets in breast Cancer. Clinica Chimica Acta. 2026;588:120989. doi:10.1016/j.cca.2026.120989
BibTeX
@article{Saleh2026,
author = {Saleh, Kamel A and Mutee, Ahmed Faisal and Kubaev, Aziz and Ochilova, Dilorom and Salih, Rasim M and Jaber, Mohamed Adil and Hussen, Safa},
title = {Small extracellular vesicles as biomarkers and therapeutic targets in breast Cancer},
journal = {Clinica Chimica Acta},
year = {2026},
volume = {588},
pages = {120989},
doi = {10.1016/j.cca.2026.120989}
}
EUVIMED